NCT06948435: A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- State
- Under way
- Phase
- Phase 3
- People
- 487 planned
- Started
- 30 Apr 2025
- Primary completion
- Sep 2027
- Arms
- Orforglipron
- Results
- None posted
- 29 Apr 2025: Trial registered
- 30 Apr 2025: Trial started